 |
市场调查报告书
商品编码
1741359
大肠桿菌菌株市场：按菌株类型、按应用、按致病性、按最终用户、按地区Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography |
||||||
大肠桿菌菌株市场规模预计在 2025 年达到 22.6 亿美元，预计到 2032 年将达到 36.1 亿美元，2025 年至 2032 年的复合年增长率为 6.9%。
| 分析范围 | 分析详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 市场规模（2025年） | 22.6亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期内的复合年增长率（2025-2032） | 6.90% | 预计金额（2032年） | 36.1亿美元 |
大肠桿菌，俗称E. coli，是一种由于其多样性和在研究中的广泛应用而引起重大科学兴趣的细菌菌株。该细菌属于肠桿菌科，通常存在于人类和动物的消化道中。虽然大肠桿菌经常与食物中毒和感染疾病有关，但值得注意的是，并非所有菌株都是有害的。事实上，许多菌株是有益的，在消化器官系统中发挥重要作用，帮助分解食物和吸收营养。然而，一些大肠桿菌菌株是致病的，可引起各种疾病，从轻微的胃肠道疾病到严重的疾病，如尿道感染、肺炎，甚至危及生命的溶血性尿毒症综合症。大肠桿菌能够引起如此广泛的疾病，使其成为一个重大的公共卫生问题。大肠桿菌的多样性及其在健康和疾病中的作用使其成为科学研究极为重要的模型生物。大肠桿菌在遗传学、生物化学和生物技术领域得到了广泛的研究，大大促进了我们对这些领域的理解。研究人员利用大肠桿菌研究细菌遗传学、代谢途径，并开发新的生物技术应用。这项广泛的研究不仅加深了我们对细菌本身的认识，也为更广泛的生物过程提供了宝贵的见解。
市场动态：
生物技术研究、重组蛋白生产和药物开发预计将在预测期内推动全球大肠桿菌菌株市场的成长。此外，工业生产也有望在预测期内推动全球大肠桿菌菌株市场的成长。生物製药生产、合成生物学、个人化医疗和生物修復预计将在预测期内为全球大肠桿菌市场提供成长机会。
然而，预计安全和生物安全问题、监管障碍、与其他微生物的竞争以及污染和交叉污染的风险将在预测期内阻碍大肠桿菌菌株市场的成长。
本报告的主要特点
- 本报告对全球大肠桿菌菌株市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
- 它还强调了每个细分市场的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球大肠桿菌菌株市场的主要企业简介根据以下参数列出，例如公司概况、产品系列、主要亮点、财务绩效和策略。
- 透过本报告的见解，负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
- 「大肠桿菌菌株市场」报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过用于分析全球大肠桿菌菌株市场的各种策略矩阵来促进他们的决策。
目录
第一章 分析目标与前提条件
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map (COM)
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 预计生物技术研究将在预测期内推动市场成长
- 限制因素
- 预计对安全和生物安全的担忧将在预测期内阻碍市场成长。
- 机会
- 个人化医疗，为精准医疗应用提供客製化的大肠桿菌菌株，预计将提供市场机会。
- 主要亮点
- 监管情景
- 产品发布/核准
- PEST分析
- 波特五力分析
- 企业合併（M&A）和联盟分析
4. 大肠桿菌菌株市场：COVID-19感染疾病的影响
- COVID-19流行病学
- 供需侧分析
- 经济影响
5. 大肠桿菌菌株市场（依菌株类型划分）（2020-2032）
- 共生菌株
- 引起腹泻的菌株
- 肠外致病菌株
- 泌尿道致病菌株
- 新生儿脑膜炎双球菌菌株
- 其他的
第六章 大肠桿菌菌株市场：依应用（2020-2032 年）
- 诊断
- 研究
- 治疗
- 重组蛋白生产
- 品管生物体
- 其他的
第七章 大肠桿菌菌株市场：致病性（2020-2032）
- 致病性大肠桿菌
- 非致病性大肠桿菌
8. 大肠桿菌菌株市场（依最终用户划分）（2020-2032 年）
- 研究所
- 诊断实验室
- 製药和生物技术公司
- CRO（委外研发机构）
- 其他的
9. 大肠桿菌菌株市场（按地区划分） (2020-2032)
- 北美洲
- 欧洲
- 亚太地区
- 拉丁美洲
- 中东
- 非洲
第十章 竞争格局
- 公司简介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Novozymes A/S
- QIAGEN NV
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- Sanofi
- Xiamen Innovax Biotech Co., Ltd
第 11 章 章节
- 参考
- 调查方法
- 关于出版商
Escherichia Coli Strain Market is estimated to be valued at USD 2.26 Bn in 2025 and is expected to reach USD 3.61 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.26 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.90% | 2032 Value Projection: | USD 3.61 Bn |
Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.
Market Dynamics:
Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.
However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market
Detailed Segmentation:
- Escherichia Coli Strain Market, By Strain Type:
- Commensal strains
- Diarrheal strains
- Extraintestinal pathogenic strains
- Uropathogenic strains
- Neonatal meningitis strains
- Others
- Escherichia Coli Strain Market, By Application:
- Diagnostics
- Research
- Therapeutics
- Production of recombinant proteins
- Quality control organisms
- Others
- Escherichia Coli Strain Market, By Pathogenicity:
- Pathogenic E. coli
- Non-pathogenic E. coli
- Escherichia Coli Strain Market, By End User:
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Others
- Escherichia Coli Strain Market, By Geography:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Novozymes A/S
- QIAGEN N.V.
- Promega Corporation
- Agilent Technologies, Inc.
- New England Biolabs, Inc.
- Takara Bio Inc.
- Bio-Rad Laboratories, Inc.
- GenScript Biotech Corporation
- Sanofi
- Xiamen Innovax Biotech Co., Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Strain Type
- Market Snippet, By Application
- Market Snippet, By Pathogenicity
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Biotechnology research is expected to drive the market growth over forecast period
- Restraints
- Safety and biosecurity concerns is expected to hinder the market growth over forecast period
- Opportunities
- Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Escherichia Coli Strain Market, By Strain Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Commensal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diarrheal strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Extraintestinal pathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Uropathogenic strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Neonatal meningitis strains
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Escherichia Coli Strain Market, By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Production of recombinant proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Quality control organisms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%) Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Non-pathogenic E. coli
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Escherichia Coli Strain Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Escherichia Coli Strain Market, By Geography, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profile
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novozymes A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Xiamen Innovax Biotech Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us
